FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990300258> ?p ?o ?g. }

• W1990300258 endingPage "245" @default.
• W1990300258 startingPage "241" @default.
• W1990300258 abstract "The aim of this study was to determine whether the addition of ezetimibe to ongoing statin therapy in patients with atherosclerosis and metabolic syndrome would favorably affect levels of inflammatory markers and adipokines. Individuals with the metabolic syndrome exhibit higher levels of inflammatory biomarkers and adipokines, which have been implicated in the pathobiology of cardiovascular risk. The impact of the addition of ezetimibe to statin therapy on these proinflammatory mediators is unclear. Fifty patients with metabolic syndrome and concomitant vascular disease receiving stable statin monotherapy, with low-density lipoprotein cholesterol (LDL-C) levels >77.4 mg/dL (>2.0 mM), were treated with ezetimibe 10 mg per day for 12 weeks. The primary study end point was the % change in adiponectin levels from baseline to 12 weeks. Secondary study end points included % changes in the levels of other circulating inflammatory markers, adipokines, and plasma lipids. The addition of ezetimibe to statin therapy resulted in a significant reduction in total cholesterol and LDL-C and the ratio of total cholesterol to high-density lipoprotein cholesterol. However, ezetimibe add-on treatment had no effect on the primary outcome of plasma adiponectin or on any of the secondary outcomes, including leptin, hsCRP, tumor necrosis factor-α, or interleukin-6 concentrations. These observations remained unchanged after adjusting for body mass index and for background statin used. The addition of ezetimibe to stable statin therapy in patients with vascular disease and metabolic syndrome, who were not at guideline recommended LDL-C levels, did not alter adipokine levels after 12 weeks. Short-term add-on with ezetimibe may not be associated with additional inflammatory benefits beyond improvements in cholesterol homeostasis." @default.
• W1990300258 created "2016-06-24" @default.
• W1990300258 creator A5018121224 @default.
• W1990300258 creator A5023942807 @default.
• W1990300258 creator A5047936944 @default.
• W1990300258 creator A5048139849 @default.
• W1990300258 creator A5053275833 @default.
• W1990300258 creator A5064509338 @default.
• W1990300258 creator A5080334509 @default.
• W1990300258 creator A5083162330 @default.
• W1990300258 creator A5086698591 @default.
• W1990300258 date "2010-09-01" @default.
• W1990300258 modified "2023-10-05" @default.
• W1990300258 title "Effects of Ezetimibe Add-on to Statin Therapy on Adipokine Production in Patients With Metabolic Syndrome and Stable Vascular Disease" @default.
• W1990300258 cites W103327987 @default.
• W1990300258 cites W1458263521 @default.
• W1990300258 cites W156853490 @default.
• W1990300258 cites W1987507883 @default.
• W1990300258 cites W2014858276 @default.
• W1990300258 cites W2021149636 @default.
• W1990300258 cites W2024334311 @default.
• W1990300258 cites W2037251934 @default.
• W1990300258 cites W2043180355 @default.
• W1990300258 cites W2044264351 @default.
• W1990300258 cites W2096562809 @default.
• W1990300258 cites W2111385165 @default.
• W1990300258 cites W2114027342 @default.
• W1990300258 cites W2120289695 @default.
• W1990300258 cites W2128261373 @default.
• W1990300258 cites W2135050619 @default.
• W1990300258 cites W2136202715 @default.
• W1990300258 cites W2137983259 @default.
• W1990300258 cites W2148828990 @default.
• W1990300258 cites W2163414121 @default.
• W1990300258 cites W2164324917 @default.
• W1990300258 cites W2168536185 @default.
• W1990300258 cites W2187593761 @default.
• W1990300258 cites W2329306090 @default.
• W1990300258 doi "https://doi.org/10.1097/fjc.0b013e3181e7fd74" @default.
• W1990300258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20505518" @default.
• W1990300258 hasPublicationYear "2010" @default.
• W1990300258 type Work @default.
• W1990300258 sameAs 1990300258 @default.
• W1990300258 citedByCount "8" @default.
• W1990300258 countsByYear W19903002582012 @default.
• W1990300258 countsByYear W19903002582013 @default.
• W1990300258 countsByYear W19903002582014 @default.
• W1990300258 countsByYear W19903002582017 @default.
• W1990300258 countsByYear W19903002582021 @default.
• W1990300258 crossrefType "journal-article" @default.
• W1990300258 hasAuthorship W1990300258A5018121224 @default.
• W1990300258 hasAuthorship W1990300258A5023942807 @default.
• W1990300258 hasAuthorship W1990300258A5047936944 @default.
• W1990300258 hasAuthorship W1990300258A5048139849 @default.
• W1990300258 hasAuthorship W1990300258A5053275833 @default.
• W1990300258 hasAuthorship W1990300258A5064509338 @default.
• W1990300258 hasAuthorship W1990300258A5080334509 @default.
• W1990300258 hasAuthorship W1990300258A5083162330 @default.
• W1990300258 hasAuthorship W1990300258A5086698591 @default.
• W1990300258 hasConcept C126322002 @default.
• W1990300258 hasConcept C134018914 @default.
• W1990300258 hasConcept C194832188 @default.
• W1990300258 hasConcept C2776782570 @default.
• W1990300258 hasConcept C2776839432 @default.
• W1990300258 hasConcept C2777391703 @default.
• W1990300258 hasConcept C2777482532 @default.
• W1990300258 hasConcept C2778163477 @default.
• W1990300258 hasConcept C2778657065 @default.
• W1990300258 hasConcept C2780578515 @default.
• W1990300258 hasConcept C2780613262 @default.
• W1990300258 hasConcept C511355011 @default.
• W1990300258 hasConcept C71924100 @default.
• W1990300258 hasConcept C90924648 @default.
• W1990300258 hasConceptScore W1990300258C126322002 @default.
• W1990300258 hasConceptScore W1990300258C134018914 @default.
• W1990300258 hasConceptScore W1990300258C194832188 @default.
• W1990300258 hasConceptScore W1990300258C2776782570 @default.
• W1990300258 hasConceptScore W1990300258C2776839432 @default.
• W1990300258 hasConceptScore W1990300258C2777391703 @default.
• W1990300258 hasConceptScore W1990300258C2777482532 @default.
• W1990300258 hasConceptScore W1990300258C2778163477 @default.
• W1990300258 hasConceptScore W1990300258C2778657065 @default.
• W1990300258 hasConceptScore W1990300258C2780578515 @default.
• W1990300258 hasConceptScore W1990300258C2780613262 @default.
• W1990300258 hasConceptScore W1990300258C511355011 @default.
• W1990300258 hasConceptScore W1990300258C71924100 @default.
• W1990300258 hasConceptScore W1990300258C90924648 @default.
• W1990300258 hasIssue "3" @default.
• W1990300258 hasLocation W19903002581 @default.
• W1990300258 hasLocation W19903002582 @default.
• W1990300258 hasOpenAccess W1990300258 @default.
• W1990300258 hasPrimaryLocation W19903002581 @default.
• W1990300258 hasRelatedWork W128033378 @default.
• W1990300258 hasRelatedWork W1987507883 @default.
• W1990300258 hasRelatedWork W1992197441 @default.
• W1990300258 hasRelatedWork W2078849257 @default.
• W1990300258 hasRelatedWork W2102201399 @default.
• W1990300258 hasRelatedWork W2350152005 @default.

• next